Astera Labs price target raised to $130 from $95 at Jefferies

Jefferies analyst Blayne Curtis raised the firm’s price target on Astera Labs (ALAB) to $130 from $95 and keeps a Buy rating on the shares. The firm, which sees continued upside to estimates in 2025 and a “beat/raises” this earning report, believes the larger inflection will come in the second half of 2026 given its expectation that Astera supplies Scorpio X for scale-up in Trainium 3 and a new UAL switch for Trn4, the analyst tells investors. The firm, which adds that its estimates are “already above the Street” for calendar 2026, is raising its calendar 2027 EPS forecast to $2.81 from $2.32.